CAMP4 Therapeutics Corp. (CAMP)
4.39
-0.10
(-2.23%)
USD |
NASDAQ |
May 29, 16:00
4.38
-0.01
(-0.23%)
After-Hours: 20:00
CAMP4 Therapeutics EPS Diluted (Quarterly) : -0.3165 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | -1.026 |
| Praxis Precision Medicines, Inc. | -3.205 |
| Dianthus Therapeutics, Inc. | -0.8501 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.33M |
| Revenue (Quarterly) | 1.294M |
| Total Expenses (Quarterly) | 19.62M |
| Enterprise Value | 130.14M |
| Gross Profit Margin (Quarterly) | 59.81% |
| Profit Margin (Quarterly) | -1.42K% |
| Earnings Yield | -51.72% |
| Normalized Earnings Yield | -40.07 |